Edwards Lifesciences announced the FDA approved the Mitris Resilia surgical valve, a tissue valve replacement specifically designed for the heart’s mitral position.
The Mitris Resilia valve has a saddle-shaped sewing cuff that mimics the asymmetric shape of the native mitral valve, according to a company press release. It also features a low-profile frame that helps avoid obstruction of the left ventricular outflow tract by stent posts and is visible under fluoroscopy, to facilitate potential future transcatheter interventions for patients.
«For patients who need mitral valve replacement, the